Company: GIFLF
Filing Date: 2025-02-26
Form Type: 6-K
Source: 0001104659-25-017501
Chunk: 17

Company: Grifols SA
Filing Date: 2025-02-26
Form: 6-K
Chunk 17
---
 the highest ethical standards throughout the supply chain Introductory Remarks Business Performance Financials Final remarks Annex

- 24 - Q4 2024 Results Sustainability | Progress in 2024 Patients, Donors and Communities Are at the Core of Our Strategy Introductory Remarks Business Performance Financials Final remarks Annex Improving patients’ lives Improving patients’ lives +800,000 patients treated 1 +70 patient organizations supported 4 strategic lines of action Education & empowerment Awareness & visibility Patient experience Advocacy & access Our donors: a cross - section of society Improving the health of vulnerable people 930,000 + plasma donors 390+ plasma centers 90% of donors rated rate the service as excellent or very good Supporting donors’ communities 19 local organizations supported $365.374 in community investment Driving Positive Change in Our Communities $4.575 M of positive impact on plasma donors and their communities >80 local organizations supported > 1,3 M$ in community investment > 700 employees involved Allocate +$19 M to product donations +$9 M in support to patients' associations 1 Accounts for a portion of Grifols revenues (~80% of IG, FVIII, A - 1, Tavlesse and ~35% Albumin used in hepatic cirrhosis chronic setting)

- 25 - Q4 2024 Results Sustainability | Progress in 2024 Operating Responsibly by Minimizing our Environmental Impact and Prioritizing the Well - being of our Employees Introductory Remarks Business Performance Financials Final remarks Annex 23,800+ people 90+ nationalities 57% Women in total workforce 47% Women in management Gender equality 96% employees received training 270+ average training hours per employee Mental Health Index A new indicator in its Engagement Pulse Survey in 2024 to better gauge the mental health of Grifols’ workforce Our people Diversity & inclusion Awareness and educational campaigns on inclusion of minorities, LGTBIQ+ and people with disabilities Advancing to minimize our footprint GHG Emissions - 3% tCO2e/€M 2024 Reduction of emissions relative to sales (Scope 1+2+3) - 12% tCO2e 2024 Reduction of emissions scope 1+2 (market based) 2023 - 2026 Environmental Plan Outlines the objectives for this four - year period, with concrete targets assigned to Grifols’ global facilities SBTi targets approval In 2024 SBTi has validated that Grifols’